GHRP-6

It pairs a real, fast, historically important mechanism with an empty human outcomes file and the heaviest side-effect load of its group. It is one of the original growth-hormone-releasing peptides and genuinely pivotal to the science, but for the growth-hormone-optimization goal it is the weakest practical choice. The growth-hormone rise is real, per Bowers 1990, but no trial shows it produces fat loss or muscle, and the strong appetite, separate from growth hormone, per Locke 1995, actively fights a cutting goal. If you specifically want the hunger for a hard bulk, it has a niche. For almost everyone else, a selective option does the same job with fewer downsides.

✅ Best for: Experienced users running a hard mass or bulking phase who actively want the appetite boost to eat in a surplus, the one place the hunger is a feature instead of a bug. People curious about the oldest growth-hormone-releasing peptide and its place in the discovery of ghrelin. Users who already stack a GHRH peptide and want to compare the older option directly. Anyone who can source verified material with a certificate of analysis and will monitor IGF-1 and glucose. People who understand they are running an unproven, grey-market research chemical and accept that.

❌ Avoid if: You have a fat-loss goal, because the strong appetite works directly against eating less. You have active or hormone-sensitive cancer, since growth-hormone and IGF-1 signaling can promote proliferation. You are pregnant or breastfeeding, with no safety data. You have diabetes or poor glucose control, because growth hormone opposes insulin, per White 2009. You compete in tested sport, since growth-hormone-releasing peptides are banned at all times under WADA category S2. You want the cleanest option, in which case ipamorelin avoids most of the appetite and cortisol effect. You cannot verify source quality, since research-chemical contamination may exceed the intrinsic pharmacological risk.